JAZZ Jazz Pharmaceuticals plc
$207.06▲ +0.66%
Healthcare
Other
Volume 129.0K
Avg Volume (10D) 761.7K
Key Metrics & Fundamentals
Market Cap
$13.44B
P/E Ratio
14.2
Div Yield
0.00%
52W Range
128.80 - 266.38
% vs 50 MA
-12.58%
% vs 200 MA
-4.65%
RSI-14
30.4
MACD Histogram
-0.1800
Beta (1Y vs SPY)
0.52
Free Cash Flow
$243.40M
Gross Rev
$1.21B
Gross Profit
$1.09B
EBITDA
$504.30M
COGS
$116.40M
Operating Exp
$766.70M
Operating Income
$325.20M
EBIT
$325.20M
Pretax Income
$211.00M
Net Income
$192.80M
EPS (Diluted)
2.78
Price & Volume History
Loading chart…
Recent News
Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Zacks · Oct 27, 2026 9:00 AM ET
Jazz Pharmaceuticals Expects $755 Million Charge to Impact Q3 Earnings
MT Newswires · Oct 26, 2026 5:36 PM ET
Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for
Zacks · Oct 26, 2026 9:00 AM ET
Jazz Pharmaceuticals' Ziihera Shows 3-Year Survival Benefit in Gastroesophageal Cancer
MT Newswires · Oct 23, 2026 10:50 AM ET
Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026
PR Newswire · Oct 23, 2026 10:15 AM ET
Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3?
Zacks · Oct 21, 2026 10:00 AM ET
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
PR Newswire · Oct 19, 2026 4:15 PM ET
Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?
Zacks · Oct 16, 2026 8:17 AM ET
3 Healthcare Stocks That Concern Us
StockStory · Oct 16, 2026 7:31 AM ET
HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
Zacks · Oct 16, 2026 7:12 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See JAZZ's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.